Argus Research Maintains Buy on Amgen, Raises Price Target to $515
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice TargetHot
Argus Research analyst Jasper Hellweg maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $460 to $515.
Argus Research analyst Jasper Hellweg maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $460 to $515.